Abstract
Background
Chronic fatigue with a debilitating effect on daily life is a frequently reported symptom among adolescents and young adults with a history of Q-fever infection (QFS). Persisting fatigue after infection may have a biological origin with psychological and social factors contributing to the disease phenotype. This is consistent with the biopsychosocial framework, which considers fatigue to be the result of a complex interaction between biological, psychological, and social factors. In line, similar manifestations of chronic fatigue are observed in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and juvenile idiopathic arthritis (JIA). Cognitive behavioral therapy is often recommended as treatment for chronic fatigue, considering its effectiveness on the group level. However, not everybody benefits on the individual level. More treatment success at the individual level might be achieved with patient-tailored treatments that incorporate the biopsychosocial framework.
Methods
In addition to biological assessments of blood, stool, saliva, and hair, the QFS-study consists of a randomized controlled trial (RCT) in which a single-subject experimental case series (N=1) design will be implemented using Experience Sampling Methodology in fatigued adolescents and young adults with QFS, CFS/ME, and JIA (aged 12–29). With the RCT design, the effectiveness of patient-tailored PROfeel lifestyle advices will be compared against generic dietary advices in reducing fatigue severity at the group level. Pre-post analyses will be conducted to determine relevance of intervention order. By means of the N=1 design, effectiveness of both advices will be measured at the individual level.
Discussion
The QFS-study is a comprehensive study exploring disrupted biological factors and patient-tailored lifestyle advices as intervention in adolescent and young adults with QFS and similar manifestations of chronic fatigue. Practical or operational issues are expected during the study, but can be overcome through innovative study design, statistical approaches, and recruitment strategies. Ultimately, the study aims to contribute to biological research and (personalized) treatment in QFS and similar manifestations of chronic fatigue.
Trial registration
Trial NL8789. Registered July 21, 2020.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Swart, Joost F. 2 ; Houtveen, Jan 1 ; Eijkelkamp, Niels 3 ; van de Putte, Elise M. 4 ; Wulffraat, Nico M. 2 ; Nijhof, Sanne L. 4 1 University Medical Center Utrecht, Utrecht University, Department of Paediatric Rheumatology/Immunology, Wilhelmina Children’s Hospital, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234)
2 University Medical Center Utrecht, Utrecht University, Department of Paediatric Rheumatology/Immunology, Wilhelmina Children’s Hospital, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234); Utrecht University, Faculty of Medicine, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234)
3 University Medical Center Utrecht, Utrecht University, Center for Translational Immunology, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234)
4 Utrecht University, Faculty of Medicine, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234); University Medical Center Utrecht, Utrecht University, Department of Paediatrics, Wilhelmina Children’s Hospital, Utrecht, the Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234)




